MediciNova
MNOV
51 hedge funds and large institutions have $55.9M invested in MediciNova in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 5 closing their positions.
1,371% more call options, than puts
Call options by funds: $103K | Put options by funds: $7K
90% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 10
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
6% more funds holding
Funds holding: 48 → 51 (+3)
0.01% more ownership
Funds ownership: 21.61% → 21.63% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $56.2M → $55.9M (-$383K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$322K |
| 2 |
State Street
Boston,
Massachusetts
|
+$195K |
| 3 |
EA
Emerald Acquisition
Seattle,
Washington
|
+$175K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$139K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$130K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$338K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$283K |
| 3 |
D.E. Shaw & Co
New York
|
-$262K |
| 4 |
Renaissance Technologies
New York
|
-$260K |
| 5 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$149K |
MNOV Hedge Fund Activity: Q3 2016 in Review
51 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q3 2016, worth a combined $55.9M — down 0.68% from $56.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MNOV positions and 5 closed out — a net gain of 3 holders — while 19 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $322K. The largest seller was Oxford Asset Management, exiting entirely with an estimated $338K sold.
- 51 institutional investors held MediciNova (MNOV) as of Q3 2016, up from 48 in Q2 2016.
- Funds reported $55.9M of MediciNova stock for Q3 2016, down 0.68% quarter-over-quarter.
- 8 funds opened new MediciNova positions in Q3 2016 and 5 closed out, a net change of +3 holders.
- The largest MediciNova buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $322K added.
- The largest MediciNova seller in Q3 2016 was Oxford Asset Management, an estimated $338K sold.
Based on aggregated 13F filings for Q3 2016.